iShares Neuroscience and Healthcare ETF is an exchange-traded fund that provides diversified exposure to companies involved in neuroscience, neurological drug development, and related healthcare technologies. The fund focuses on businesses across biopharmaceuticals and medical technology that are working in areas such as brain health, central nervous system disorders, and innovative treatment platforms. Its portfolio includes a mix of U.S. and international companies spanning drug discovery, precision medicine, and specialized therapeutic solutions, making it a targeted way to access a niche segment of the healthcare market. By concentrating on firms tied to neuroscience innovation, iShares Neuroscience and Healthcare ETF serves as a sector-focused vehicle for investors seeking exposure to the broader healthcare ecosystem through companies active in research, development, and commercialization of neurological treatments and devices.
United States
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
What share of all ETF conversation is about IBRN?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% new | 0% new | 0% new | 0% +0 |
Of the messages about IBRN that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | — | — | — | ||
| Bearish | — | — | — | — |
Of the messages about IBRN that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Macro | — | — | — | — | ||
| Technical Analysis | — | — | — | — |
Of the messages about IBRN, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 0% | 0% | 0% | 0% | ||
| Newcomers | 100% | 100% | 100% | 100% |